TPVB, PECSB, ESPB for Postmastectmy Pain
Launched by MENOUFIA UNIVERSITY · Sep 29, 2021
Trial Information
Current as of June 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. ASA physical status classification class I or II
- • 2. Age group 18 - 60 years of the female gender
- • 3. Patients undergoing breast cancer surgeries
- Exclusion Criteria:
- • 1. Patient refusal
- • 2. History of hypersensitivity to local anesthetics
- • 3. Bleeding disorders or patients receiving anticoagulants
- • 4. Spine or chest wall deformities
- • 5. Pregnancy
- • 6. Local infection at the site of injection.
About Menoufia University
Menoufia University is a prominent educational and research institution located in Egypt, dedicated to advancing medical science and improving healthcare outcomes through innovative clinical research. The university's clinical trial sponsorship is characterized by a commitment to ethical standards, rigorous scientific methodology, and collaboration with multidisciplinary teams. By leveraging its academic resources and expertise, Menoufia University aims to contribute to the development of new therapies and interventions, ultimately enhancing patient care and public health within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shibīn Al Kawm, Menofia, Egypt
Patients applied
Trial Officials
kareem M mikhimer, m.sc
Principal Investigator
assistant fellow, Ahmed Maher Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials